According to a news release from Benchmark Plc, the internet marketing authorisation (MA) marks an vital milestone towards optimal performance of the sea lice treatment. The MA permits aquaculture professionals to re-use Ectosan Vet remedy water for a second batch of fish, as lengthy as water top quality parameters are preserved to the satisfaction of the prescribing veterinarian.
“We are very delighted to have been granted a variation to the marketing authorisation from the Norwegian Medicines Company,” Benchmark CEO Trond Wiliksen stated. “Ectosan Vet and CleanTreat is a significantly-desired solution for the marketplace which proceeds to clearly show superb success with efficacy previously mentioned 99 % as properly as fantastic operational performance.”
The double-use system will enhance the effectiveness of treatment plans as a producer will be ready to take care of a salmon farm more successfully with a resolution that delivers far more than 99 p.c efficacy, promotes animal welfare, decreases mortality and protects the environment – driving sustainability in the market.
This MA variation represents a further more essential phase in the direction of Benchmark’s purpose of optimising the efficiency of their medicinal sea lice solutions, and further trials are ongoing to guidance several re-use of procedure water.
“It is the to start with medicinal solution brought to the Norwegian market in about ten several years which addresses just one of the greatest problems in salmon output, when improving animal welfare, lessening mortality and safeguarding the setting.” Wiliksen concluded.